UPDATE: Biogen Says Alzheimer's Drug Shows Significant Reduction in Amyloid Brain Plaque, Slows Cognitive Decline vs Placebo in Phase I Study; Enrollment in Phase III Trial to Begin Later This Year
Charles Gross